AKT1 and malignant colon neoplasm: The result revealed that silence SNHG20 inhibited PI3K/AKT pathway activation in 5-FU drug-resistant colon cancer cells to promote the apoptosis of drug-resistant colon cancer cells and reduce the drug-resistance of cells.